Ligand profile
ZINC197145031
Virtual-screening candidate from ZINC.
Bound to: KP13_06703 — Carbepenem-hydrolyzing beta-lactamase KPC2
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC197145031- UniProt (similar protein)
Q93LQ9- Tanimoto
- 0.738
- Target protein
- KP13_06703
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 86.3
- −1 ≤ LogP ≤ 5 1.44
- MW ≤ 500 Da 276.1
- LogP ≤ 5 1.44
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 86.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1C#NN#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1C#N
InChI=1S/C15H9BN2O3/c17-7-10-1-2-13(5-11(10)8-18)21-14-3-4-15-12(6-14)9-20-16(15)19/h1-6,19H,9H2InChI=1S/C15H9BN2O3/c17-7-10-1-2-13(5-11(10)8-18)21-14-3-4-15-12(6-14)9-20-16(15)19/h1-6,19H,9H2
UBMGTTRDNUKZMT-UHFFFAOYSA-NUBMGTTRDNUKZMT-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CHEMBL484785
- Homolog
- Q93LQ9
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC197145031 →
- ZINC ZINC20 ZINC197145031 →
- UniProt UniProt Q93LQ9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC197145031”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_06703.
PDB 36
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).